April 2018
Providence Cancer Institute is currently conducting more than 130 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.
Immunotherapy studies for advanced melanoma
Providence Cancer Institute, an international leader in melanoma research and treatment, currently has more than 10 studies of investiga-tional and FDA-approved immunotherapies open for people with advanced melanoma, including two new studies:

  • A Phase 1 dose-escalating trial of AEB1102

All current open studies:
Find additional studies for many types of cancer in Multiple Tumor Types.
New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.